3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
31
Testicular Neoplasms
4
Breast Neoplasms
4
Vomiting
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Testicular Germ Cell Tumor
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms
2
Nausea
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Neutrophilic, Chronic
2
Leukemia, Myelomonocytic, Chronic
2
Interventions
Gemcitabine
11
pembrolizumab
8
enfortumab vedotin
8
Specimen Handling
8
Cisplatin
8
Magnetic Resonance Spectroscopy
6
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Biopsy
3
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Platinum
2
Ipilimumab
2
Immunoglobulin G
2
Doxorubicin
2
Docetaxel
2
Disulfides
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tocilizumab
1
tamibarotene
1
rucaparib
1
relatlimab
1
pegfilgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Dexamethasone
×
Genitourinary
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled